pH Associates: European joint working in the evaluation of the Infliximab Paediatric Crohn’s Disease Education Plan

pH Associates, working in partnership with contemporaries across Europe have recently completed a multi-centre, cross sectional evaluation of the Infliximab Paediatric Crohn’s Disease Educational Plan. Findings of the evaluation are published this week in Drug Safety (Drug safety 2010; 33 (6) pages: 489 – 501).

Our Real World Evidence Analyst and Data Management team has grown
January 25, 2019

Poster Presentations at ISPOR 21st Annual European Congress
November 5, 2018

Meet our Patient Centred Outcomes Team at ISOQOL 24-27th October, Dublin.
October 23, 2018

Evidence in Digital Therapeutics – Proof and Power
September 25, 2018

pH Associates welcomes 4 new recruits!
July 27, 2018

The patient’s voice WILL be heard in drug development: draft FDA guidance on collecting patient experience data
June 13, 2018